Making best practice, everyday practice

Login Register

SGLT-2 inhibitors in type 2 diabetes – protecting the kidney (and heart) beyond glucose control

Protect the kidney and therefore the heart of diabetic patients by optimising therapy - use ACE-inhibitors, ARBs and SGLT-2 inhibitors appropriately.

Do you like this? If you want to share it:

Do you like this? Share with a colleague